Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Liabilities and Shareholders Equity (2018 - 2025)

Verastem (VSTM) has 8 years of Liabilities and Shareholders Equity data on record, last reported at $246.4 million in Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 142.71% year-over-year to $246.4 million; the TTM value through Dec 2025 reached $751.3 million, up 64.32%, while the annual FY2025 figure was $246.4 million, 142.71% up from the prior year.
  • Liabilities and Shareholders Equity reached $246.4 million in Q4 2025 per VSTM's latest filing, up from $176.9 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $246.4 million in Q4 2025 and bottomed at $95.0 million in Q4 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $137.5 million, with a median of $123.7 million recorded in 2021.
  • Peak YoY movement for Liabilities and Shareholders Equity: crashed 48.63% in 2021, then soared 142.71% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $108.7 million in 2021, then fell by 12.53% to $95.0 million in 2022, then soared by 57.51% to $149.7 million in 2023, then tumbled by 32.18% to $101.5 million in 2024, then skyrocketed by 142.71% to $246.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $246.4 million in Q4 2025, $176.9 million in Q3 2025, and $196.3 million in Q2 2025.